214 related articles for article (PubMed ID: 28922388)
21. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
22. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
23. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
[TBL] [Abstract][Full Text] [Related]
24. Identification of NCAPH as a biomarker for prognosis of breast cancer.
Lu H; Shi C; Wang S; Yang C; Wan X; Luo Y; Tian L; Li L
Mol Biol Rep; 2020 Oct; 47(10):7831-7842. PubMed ID: 33009967
[TBL] [Abstract][Full Text] [Related]
25. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of
Chetry M; Li S; Liu H; Hu X; Zhu X
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29472315
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Values of Transforming Growth Factor-Beta Subtypes in Ovarian Cancer.
Zhou J; Jiang W; Huang W; Ye M; Zhu X
Biomed Res Int; 2020; 2020():2170606. PubMed ID: 32351985
[TBL] [Abstract][Full Text] [Related]
28. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement.
Hata K; Nishijima K; Mizuguchi J
Exp Cell Res; 2007 Jul; 313(11):2356-66. PubMed ID: 17466295
[TBL] [Abstract][Full Text] [Related]
29. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
[TBL] [Abstract][Full Text] [Related]
30. Prognostic values of S100 family mRNA expression in ovarian cancer.
Ma N; Zhu L; Yang L; Cui Y; Zhan Y
Cancer Biomark; 2019; 25(1):67-78. PubMed ID: 31033462
[TBL] [Abstract][Full Text] [Related]
31. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
32. Transcription levels and prognostic significance of the NFI family members in human cancers.
Li Y; Sun C; Tan Y; Li L; Zhang H; Liang Y; Zeng J; Zou H
PeerJ; 2020; 8():e8816. PubMed ID: 32219034
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer.
Luo P; Lu G; Fan LL; Zhong X; Yang H; Xie R; Lv Z; Lv QZ; Fu D; Yang LX; Ma Y
Oncol Rep; 2017 Apr; 37(4):2057-2062. PubMed ID: 28260080
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
35. A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patients.
Stein WD; Litman T; Fojo T; Bates SE
Biochim Biophys Acta; 2007 Jun; 1770(6):857-71. PubMed ID: 17398010
[TBL] [Abstract][Full Text] [Related]
36. Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in Malignancies.
Feng G; Guo K; Yan Q; Ye Y; Shen M; Ruan S; Qiu S
Med Sci Monit; 2019 May; 25():3374-3389. PubMed ID: 31063460
[TBL] [Abstract][Full Text] [Related]
37. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
38. Enabled homolog shown to be a potential biomarker and prognostic indicator for breast cancer by bioinformatics analysis.
Li QL; Su YL; Zeng M; Shen WX
Clin Invest Med; 2019 Jan; 41(4):E186-E195. PubMed ID: 30737978
[TBL] [Abstract][Full Text] [Related]
39. BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation.
Stupfler B; Birck C; Séraphin B; Mauxion F
Nat Commun; 2016 Feb; 7():10811. PubMed ID: 26912148
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
